Author： Shiozawa S.
Publisher： Adis International
ISSN： 1173-8804
Source： BioDrugs, Vol.13, Iss.5, 2000-05, pp. : 305-311
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treatment of Multiple Sclerosis with the Interferon- s: Comparative Risks and Benefits
By Herndon R.M.
BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. :
Access to resources
Recommend
A Role for Interferon- in Guillain-Barré Syndrome?
By Créange A.
BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. :
Interferon Alfacon-1: A Novel Interferon for the Treatment of Chronic Hepatitis C
By Alberti A.
BioDrugs, Vol. 12, Iss. 5, 1999-11 ,pp. :
Opening speech at China’s General Practice Conference
Family Medicine and Community Health, Vol. 3, Iss. 4, 2015-12 ,pp. :